D-dimer rise in outpatients with COVID 19 and comorbidities
Introduction: COVID-19 is an infectious disease caused by a newly discovered Coronavirus. Most of the infected people will go through it with mild to moderate respiratory symptoms and recover without any specific treatment. Older people and people with medical issues, such as cardiovascular diseases...
Saved in:
Main Author: | Miljković Ana R. |
---|---|
Format: | article |
Language: | EN SR |
Published: |
Serbian Medical Society, Belgrade
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/b64e7e57dc664c6cbde2f3ebf63d26c5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of Prognosis and Risk of Death by Neutrophil/Lymphocyte Ratio, C-Reactive Protein/Albumin Ratio and Plasma D-Dimer in Patients with Pulmonary Thromboembolism
by: Shan T, et al.
Published: (2021) -
Biochemical role of serum ferratin and d-dimer parameters in COVID 19 diagnosis
by: Abdullah Farasani
Published: (2021) -
Characteristics and treatment of coagulopathy associated with COVID-19
by: Miljić Predrag
Published: (2021) -
Venous Thromboembolism in COVID-19 Compared to Non-COVID-19 Cohorts: A Systematic Review with Meta-Analysis
by: Antonella Tufano, et al.
Published: (2021) -
Ratios between circulating myeloid cells and lymphocytes are associated with mortality in severe COVID-19 patients
by: Ma Hui, et al.
Published: (2021)